Vaxcyte share price logo

Vaxcyte

NASDAQ: PCVX

Large Cap

$63.61

-1.66

(-2.54%)

as on

Vaxcyte Stock Performance

as on October 17, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $62.54
    $65.34
    downward going graph

    1.68%

    Downside

    2.72%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $39.87
    $90.75
    downward going graph

    37.32%

    Downside

    42.67%

    Upside

    downward going graph

Vaxcyte share price movements today

Previous Close
$65.27
Open
$65.13
Volume
2.4M
Market Cap
$10.6B
Day's Low - High
$62.54 - $65.34
52 Week Low - High
$39.87 - $90.75

Vaxcyte Historical Returns

1 Month Return
+ 11.06 %
3 Month Return
+ 16.47 %
1 Year Return
+ 49.74 %
3 Year Return
+ 39.23 %
5 Year Return
+ 167.39 %

Vaxcyte Stock Fundamentals & Key Indicators

Check Vaxcyte market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$10.6B

EPS (TTM)

-7.64

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-8.54

Industry PE ratio

9.31

PEG Ratio

0.17

EBITDA

-1.0B

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-37.57%

Vaxcyte vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Vaxcyte with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Vaxcyte image
Vaxcyte
StrongBuy$10.6B167.39%-8.540.00%0.00%
Moderna image
Moderna
Neutral$90.3B-27.05%-29.64-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$126.4B179.89%28.7886.04%0.00%
Regeneron image
Regeneron
Buy$77.5B43.94%19.0184.86%0.48%

Stock Returns calculator for Vaxcyte Stock including INR - Dollar returns

The Vaxcyte stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Vaxcyte investment value today

Current value as on today

₹1,57,810

Returns

₹57,810

(+57.81%)

Returns from Vaxcyte Stock

₹45,928 (+45.93%)

Dollar Impact

₹11,882 (+11.88%)

Analyst Recommendation on Vaxcyte Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71428571428571% of analysts recommend a 'BUY' rating for Vaxcyte. Average target price of $117.3

Vaxcyte Share Price Target

Get share price movements and forecasts by analysts on Vaxcyte.

What analysts predicted

45.77%UPSIDE

Target Price

$117.3

Current Price

$63.61

Analyzed by

7 Analysts

High

$146

Target

$117.30

Low

$75

Vaxcyte target price $117.3, a slight upside of 45.77% compared to current price of $63.61. According to 7 analysts rating.

Indian Investors' Interest in Vaxcyte Stock

Investment in Vaxcyte Shares on INDmoney has grown by 1983.33% in the last 30 days, indicating increased investment activity.

Time period: to

Change:1983.33% versus previous 30 day period

Search interest for Vaxcyte Stock has increased by 838% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:838% versus previous 30 day period

Vaxcyte Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-4
-
4
-5
-
Operating Income
-114
-152
-139
-162
-180
-226
-242
-274
-345
-302
EBITDA
-91
-125
-135
-52
-135
-161
-207
-236
-314
-289
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
3
3
4
4
4
4
5
9
5
5
Income Before Tax
-95
-128
-103
-137
-140
-166
-212
-246
-320
-284
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-95
-128
-103
-137
-140
-166
-212
-246
-320
-284
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Vaxcyte Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
-
-1
-1
-1
-
-
-
-
-
Operating Income
-17
-35
-54
-89
-103
-232
-468
-569
-923
EBITDA
-17
-28
-49
-87
-96
-214
-392
-448
-741
Interest Expense
-
0
0
0
0
0
-
-
-
Depreciation
0
1
1
1
3
9
10
15
24
Income Before Tax
-17
-29
-50
-89
-100
-223
-402
-463
-766
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-17
-29
-50
-89
-100
-223
-402
-463
-766
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Vaxcyte Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-95
-128
-103
-137
-140
-166
-212
-246
-320
-604
Operating Cash Flow
-159
-121
-60
-111
-166
-121
-143
-224
-280
-513
Investing Cash Flow
-451
-80
-917
-557
123
77
121
115
-233
-85
Financing Cash Flow
818
110
1,515
4
0
2
-3
2
601
607
Change in Cash
214
-92
531
-662
-41
-40
-25
-107
86
9

Vaxcyte Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
-29
-50
-89
-100
-223
-402
-463
-766
Operating Cash Flow
0
-30
-47
-46
-121
-170
-296
-452
-655
Investing Cash Flow
0
-1
-1
-1
-212
74
-773
-2,005
437
Financing Cash Flow
0
62
41
374
17
861
639
2,448
2
Change in Cash
0
29
-7
327
-316
765
-436
-9
-213

Global Institutional Holdings in Vaxcyte

Check out the Institutions with significant holdings in Vaxcyte.

Funds
Holdings
Vanguard
8.36%
Peter Kolchinsky
7.48%
VANGUARD INDEX FUNDS
7.30%
JANUS INVESTMENT FUND
5.82%
iShares
4.36%
See all

Vaxcyte News & Key Events

    Insights on Vaxcyte

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 1 month, PCVX stock has moved up by 11.1%

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Moderna, Inc. Common Stock has given 771.4% return, outperforming this stock by 721.7%

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Moderna, Inc. Common Stock has given 157.2% return, outperforming this stock by 118.0%

    About Vaxcyte

    Vaxcyte, Inc. is a biotechnology firm in the clinical development stage, dedicated to creating innovative protein-based vaccines. Its primary objective is to either prevent or manage bacterial infectious diseases. The company's leading vaccine candidate is VAX-24, an experimental 24-valent pneumococcal conjugate vaccine currently undergoing Phase 1/2 clinical trials, intended to address invasive pneumococcal disease and pneumonia. Beyond its flagship candidate, Vaxcyte is also advancing several other vaccine programs: VAX-XP, designed to offer protection against emergent bacterial strains and counter antimicrobial resistance; VAX-A1, a conjugate vaccine formulation aimed at Group A Streptococcus; and VAX-PG, a novel protein vaccine specifically developed to target the key pathogen responsible for periodontitis. The organization, which was initially established as SutroVax, Inc., officially rebranded as Vaxcyte, Inc. in May 2020. Founded in 2013, its corporate headquarters are situated in San Carlos, California.
    OrganisationVaxcyte
    Headquarters825 Industrial Road, San Carlos, CA, 94070, US
    IndustryBiotechnology
    CEOGrant E. Pickering

    Key Management of Vaxcyte

    Name

    Title

    Dr. Jeff Fairman Ph.D.

    Co-Founder & VP of Research

    Ms. Janet Graesser

    Senior Vice President of Corporate Affairs

    Mr. Grant E. Pickering M.B.A.

    Co-Founder, CEO & Director

    Mr. Harpreet S. Dhaliwal M.B.A.

    Chief Technical Operations Officer

    Ms. Elvia Cowan

    Senior VP of Finance & Chief Accounting Officer

    Mr. Jeff Macdonald

    Executive Director of Investor Relations

    Mr. David McAvoy J.D.

    Chief Legal Officer, Chief Compliance Officer & Corporate Secretary

    Ms. Whitney Jones

    Chief People Officer

    Mr. Andrew L. Guggenhime M.B.A.

    President & CFO

    Mr. James T. Wassil M.B.A., M.S.

    Executive VP, Chief Scientific Officer & COO

    FAQs

    What is Vaxcyte share price today?

    Vaxcyte share price today is $63.61 as on at the close of the market. Vaxcyte share today touched a day high of $65.34 and a low of $62.54.

    What is the 52 week high and 52 week low for Vaxcyte share?

    Vaxcyte share touched a 52 week high of $90.75 on and a 52 week low of $39.87 on . Vaxcyte stock price today i.e. is closed at $63.61,which is 29.91% down from its 52 week high and 59.54% up from its 52 week low.

    What is Vaxcyte's market capitalisation today?

    Vaxcyte market capitalisation is $0.01T as on .

    How to invest in Vaxcyte Stock (PCVX) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Vaxcyte on INDmoney app. Click on Buy button.

    What is the minimum amount required to buy Vaxcyte Stock (PCVX) from India?

    Indian investors can start investing in Vaxcyte (PCVX) shares with as little as ₹94.95999908447266 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹949.60 in Vaxcyte stock (as per the Rupee-Dollar exchange rate as on ). Based on Vaxcyte share’s latest price of $63.61 as on October 17, 2026 at 1:29 am IST, you will get 0.1572 shares of Vaxcyte. Learn more about fractional shares .

    What are the returns that Vaxcyte has given to Indian investors in the last 5 years?

    Vaxcyte stock has given 167.39% share price returns and 27.65% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?